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Prior genetic analysis suggests that the vaccinia virus J3 gene product, previously characterized as a bifunctional
(nucleoside-29-O-)-methyltransferase and poly(A) polymerase stimulatory factor, is a postreplicative positive transcription
elongation factor. To test this hypothesis, viruses bearing mutations in the J3 gene were characterized with respect to viral
protein and RNA synthesis in infected cells. The analysis reveals that compared to wt virus infections, J3 mutants synthesize
reduced amounts of large late viral proteins and shorter-than-normal intermediate and late mRNAs. Structural analysis of one
late mRNA shows that it is specifically truncated from the 39 end, thus accounting for its shorter than normal chain length.
Thus J3 mutant viruses are defective in elongation of transcription of postreplicative viral genes, strongly suggesting that the
J3 gene product normally acts as a positive transcription elongation factor. Biochemical analysis of one J3 missense mutant
demonstrates that it retains poly(A) stimulatory activity but is defective in (nucleoside-29-O-)-methyltransferase activity. Thus
the elongation factor activity of the J3 gene product is independent of the poly(A) stimulatory activity. It remains to be
determined whether the (nucleoside-29-O-)-methyltransferase and elongation factor activities of the J3 protein are linked or
can be uncoupled by mutation. © 2000 Academic Press
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Prior genetic analysis suggests that the vaccinia virus
J3 protein, previously characterized as a bifunctional
(nucleoside-29-O-)-methyltransferase and poly(A) poly-
merase stimulatory factor, is also a positive transcription
elongation factor (Latner et al., 2000). Specifically, J3
mutants have been isolated that, like mutants in the
vaccinia gene G2 positive transcription elongation factor,
compensate for treatments that promote transcription
readthrough late during vaccinia infection, namely muta-
tion of the A18 transcript release factor or treatment with
the antipoxviral drug isatin-b-thiosemicarbazone (IBT)
(Black and Condit, 1996; Condit et al., 1996; Xiang et al.,
998; Lackner and Condit, 2000). Furthermore one of the
3 mutants studied, J3x, contains a single missense mu-
ation (G96D) that affects a residue that is located very
ear the J3 methyltransferase active site and removed
rom the poly(A) stimulatory domain, suggesting this mu-
ant enzyme may be defective in methyltransferase ac-
ivity, but may retain poly(A) stimulatory activity. In this
aper, we demonstrate that J3 mutant viruses produce 39
runcated postreplicative viral mRNAs in vivo and that the
96D mutant is also specifically defective in methyl-
ransferase in vitro.
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356RESULTS
henotypic analysis of J3 mutants
Several viruses carrying mutations in the J3 gene were
ubjected to a phenotypic analysis, including analysis of
rotein and RNA synthesis in infected cells and analysis
f 39 end structure of mutant RNAs (Table 1). Two differ-
nt viruses were analyzed that contain mutations in the
3 gene only (Latner et al., 2000). One, J3x, contains a
glycine to aspartic acid missense mutation at codon 96
(G96D) near the methyltransferase active site of the 333-
amino-acid J3 protein. The other, J3-7, contains a frame-
shifting single nucleotide deletion resulting in production
of a 58-amino-acid truncated version of the J3 protein.
Both mutants are dependent for growth on the antipox-
viral drug IBT, which during a wt infection seems to
cause abnormal transcription elongation characterized
by readthrough and extension of RNA 39 ends. An addi-
tional virus was analyzed, J3x23, which contains both the
J3x mutation and a temperature-sensitive allele of the
A18 gene, Cts23. Mutation of the A18 transcript release
factor also causes transcription readthrough and exten-
sion of RNA 39 ends, and J3x suppresses this mutation;
thus J3x23 is wild type in growth phenotype (ts1 and
IBTs) though it grows poorly and forms small plaques.
Because J3x23 grows poorly, stocks of this virus have a
relatively low titer, and thus the m.o.i. for high-m.o.i.
infections is limited to ;5 pfu/cell.
Viral protein synthesis. As an initial test of our predic-
tion that the J3 mutant viruses would have an in vivo
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357VACCINIA GENE J3 MUTANT CHARACTERIZATIONbiochemical phenotype similar to that of the previously
described G2 mutants, a time course of gene expression
from the J3x, J3-7, and J3x23 viruses was compared with
that of the wt virus by metabolic labeling of proteins in
infected cells. Infected cells were pulse labeled with
[35S]methionine at various times postinfection; the total
nfected cell protein was analyzed by SDS–PAGE and
utoradiography (Fig. 1). In the wt infection, host protein
ynthesis is shut off by 4 h p.i., synthesis of early proteins
egins by 2 h p.i. and subsequently decays, and synthe-
is of intermediate and late viral proteins begins by 4 h
.i. and persists for the duration of the experiment. In the
3x infection, host shutoff and synthesis of early viral
roteins are indistinguishable from those in the wt infec-
ion. Intermediate and late J3x protein synthesis is initi-
ted at the appropriate time relative to a wt infection, and
ow-MW proteins are synthesized in normal amounts;
owever, large late proteins are synthesized in reduced
mounts relative to small J3x proteins and relative to the
t infection. In the J3-7 infection, the schedule of host
hutoff and early and late proteins synthesis is some-
hat delayed compared to the schedule in the wt infec-
ion. Early J3-7 proteins and low MW J3-7 intermediate
nd late proteins are synthesized in slightly reduced
uantities; however, large late J3-7 proteins are synthe-
ized in greatly reduced amounts relative to small late
3-7 proteins and relative to a wt infection. In the J3x23
nfection, the schedule of host shutoff and viral gene
xpression is delayed compared to that of either the wt
r the J3 single-mutant infections; however, proteins are
ynthesized in relatively normal amounts. The delayed
chedule of protein synthesis observed in the J3x23
nfection likely results from the fact that this infection was
one at relatively low m.o.i. and thus may be somewhat
synchronous. Most important, large late J3x23 proteins,
lthough reduced somewhat in quantity relative to a wt
nfection, are synthesized in increased amounts relative
o the J3 single mutant infections. In summary, the most
rominent effect of J3 gene mutation on viral protein
TABLE 1
Summary of Mutant Virusea
Virus Genotype
Growth
phenotype
RNA
phenotypeb
wt wt ts1, IBTs long, PA1
ts23 A18 missense (S432F) ts, IBTs long, PA1
3x J3 missense (G96D) ts1, IBTd short, PA1
3x23 J3 missense (G96D), A18
missense (S432F)
ts1, IBTs long, PA1
3-7 J3 null frameshift ts1, IBTd short, PA2
51x4 J3 (G96D; R327K)/J4 (D22N) ts1, IBTd short, PA1
2A G2 null frameshift ts1, IBTd short, PA1
a Condit et al. (1996); Latner et al. (2000); Pacha et al. (1990).
b long, normal RNA length; short, 39 truncated RNA; PA1, normal poly
(A) tail length; PA2, short poly (A) tail length.ynthesis is a reduction in synthesis of large late pro- ieins, identical to the phenotype previously reported for
2 mutants (Black and Condit, 1996). The increase in
ynthesis of large late proteins observed in J3x23 shows
hat suppression of the J3x mutation by the A18 Cts23
utation correlates with restoration of a wt protein syn-
hesis phenotype.
Viral mRNA synthesis. We hypothesize that the defect
n protein synthesis observed in J3 mutant infections is
aused by synthesis of shorter than normal intermediate
nd late RNAs as had been previously demonstrated for
2 mutants. This hypothesis was addressed by conduct-
ng Northern blot analysis of mutant RNAs. Cells were
nfected with wt or mutant viruses, and total infected cell
NA was prepared at various times postinfection, elec-
rophoresed on denaturing formaldehyde agarose gels,
ransferred to nylon membranes, and hybridized with
tandard early (gene C11), intermediate (gene G8), and
ate (gene F17) gene riboprobes (Fig. 2). As previously
escribed, wt virus produces early RNAs that are homo-
eneous in size due to discrete transcription initiation
nd termination events, whereas intermediate and late
NAs are heterogeneous in size due to variation in 39
nd sequence. Expression of the early RNA in a wt
nfection begins immediately after infection, peaks at ;3
, and subsequently decreases to undetectable levels.
ild-type intermediate and late RNAs appear between 3
nd 6 h postinfection and persist throughout the exper-
ment. In a J3x infection, the pattern of early RNA synthe-
is is indistinguishable from the wt infection in size,
uantity, and kinetics. J3x intermediate and late RNAs are
eterogeneous in size, and they are synthesized in sim-
lar amounts and with the same kinetics as a wt infection;
owever, the average chain length of both the interme-
iate and late J3x RNAs is decreased relative to a wt
nfection. In the J3-7 infection, the schedule of synthesis
f all three classes of RNA is slightly delayed relative to
wt infection, but the amounts of RNA synthesized are
imilar to those in a wt infection. The J3-7 early RNA is
dentical in size to wt RNA. Most important, like the J3x
nfection, the J3-7 intermediate and late RNAs, although
till heterogeneous in size, have an average chain length
hat is decreased compared to wt RNA and similar to J3x
NA. In the J3x23 infection, schedule of synthesis of all
hree classes of RNA is delayed significantly relative to
he wt infection, and the RNAs are synthesized in de-
reased amounts, consistent with the J3x23 pattern of
rotein synthesis and diagnostic of a lower m.o.i., slightly
synchronous infection. The J3x23 early RNA is the same
ize as wt RNA. Importantly, the intermediate and late
3x23 RNAs, although somewhat reduced in chain length
elative to wt RNA, are nevertheless increased in size
elative to the J3 single-mutant infections. In summary,
utation of the J3 gene results in synthesis of interme-
iate and late RNAs that are reduced in size relative to a
t infection, identical to what is observed in a G2 mutantnfection (Black and Condit, 1996). Suppression of the J3x
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358 XIANG ET AL.mutation by the A18 Cts23 mutation correlates with par-
tial restoration of a wt RNA synthesis phenotype.
Analysis of late viral mRNA 39 ends. Based on the
omparison with G2 mutants, we hypothesized that J3
utants would produce intermediate or late transcripts
hat are truncated specifically from their 39 ends. To test
his hypothesis, wt and mutant F17 gene transcripts
solated 12 h p.i. were once again inspected by Northern
nalysis, this time using as probes labeled anti-sense
NA oligonucleotides that hybridize to various places
ownstream of the F17 promoter (Fig. 3). The G2 null
utant virus G2A was included in this experiment as an
dditional control. It is noteworthy that the wt F17 late
NA is somewhat unusual compared to most other late
NAs in that a relatively strong, homogeneous 1.4-kb
ranscript can be detected above the more heteroge-
eous background. This transcript is detected with
robes a–e and not with probe f, indicating that its 39 end
s localized within the region between 1160 and 1510
ownstream from the F17 promoter. Whether this homo-
eneous 39 end is formed through termination or post-
FIG. 1. Protein synthesis in wt and mutant-infected cells. Confluent m
wt, J3x, or J3-7, or m.o.i. 5 5 with J3x23, incubated at 40°C (wt, J3x, J3x2
times after infection. Pulse-labeled proteins were analyzed by SDS–PAG
infection is indicated at the top of each autoradiogram. The time at w
autoradiogram. The migration of molecular weight markers, in kDa, isranscriptional processing remains to be determinedHoward et al., 1999). Hybridization of probe a to wt and
utant RNAs shows that the F17 transcript is reduced in
ize in the J3x, J3-7, and G2A infections but normal in size
n the J3x23 infections, consistent with Northern blots
escribed above. Close inspection of the hybridization
ith probe a reveals discrete bands within the popula-
ion of J3x, J3-7, and G2A RNAs and also that the J3x
NAs are generally larger than the J3-7 and G2A RNAs.
As hybridization probes are moved progressively further
downstream from the F17 promoter, hybridization to the
smaller J3 and G2 mutant transcripts is lost until, with
probe e, only the longest transcripts remain, correspond-
ing to the full-length major F17 transcript. This pattern of
hybridization indicates that all of the short mutant tran-
scripts originate from the F17 promoter; that is, the short
F17 mutant transcripts are truncated from their 39 ends.
Quantitative analysis of F17 transcription (Fig. 3C) shows
that the total amount of hybridization to J3x, J3-7, or G2A
RNA is equal to or greater than wt near the F17 promoter
and decreases relative to the wt signal as a function of
the distance from the F17 promoter. Thus the quantifica-
ers of BSC40 cells in 35-mm dishes were infected at m.o.i. 5 10 with
°C (J3-7), and pulse labeled for 15 min with [35S]methionine at various
autoradiography; autoradiographs are shown. The mutant used for the
e pulse label was done is indicated, in hours, at the bottom of each
ed between the autoradiograms.onolay
3) or 37
E and
hich thtion shows that initiation of transcription of the F17 gene
5toradio
359VACCINIA GENE J3 MUTANT CHARACTERIZATIONin the J3 mutant infections occurs at normal levels and
confirms that the F17 RNAs are 39 truncated. By contrast
the amount of hybridization to J3x23 RNA, although re-
duced relative to wt RNA, remains constant as a function
of distance from the F17 promoter, consistent with res-
cue of the J3 mutant phenotype in the A18–J3 double-
mutant virus. Together these observations show that the
J3 single mutants produce 39 truncated late transcripts
and together with other evidence presented support the
hypothesis that the J3 protein affects the elongation or
termination of intermediate and late gene transcription.
The existence of discrete RNA species (bands) within the
39 truncated RNAs from mutant infections could reflect
preferred promoter proximal transcription pause or ter-
mination sites revealed by mutation of an elongation
factor. The fact that J3x RNAs are slightly longer than J3-7
FIG. 2. Northern analysis of RNA from wt and mutant-infected cells. C
10 with wt, J3,x or J3-7, or m.o.i. 5 5 with J3x23, incubated at 40°C (w
at various times postinfection, indicated in hours above the autorad
antisense riboprobes specific for an early (gene C11), intermediate (gen
The migration of size markers, in kb, is indicated to the right of the auor G2A RNAs may indicate that relative to the null mu-tants, the J3x point mutant retains some elongation factor
activity.
Biochemical analysis of the J3x protein
Because the J3 protein has been previously described
as having both (nucleoside-29-O-)-methyltransferase and
poly(A) stimulatory activities, it was of interest to deter-
mine whether either or both of these activities might be
correlated with the defect in transcription elongation
observed with J3 mutants. J3-7 is a null mutant, produc-
ing no detectable J3 protein, and thus must be defective
in both J3 activities. J3x, however, is a point mutation. It
produces normal amounts of J3 polypeptide, and it has a
milder phenotype than J3 null mutants. Thus, this mutant
might be expected to retain some normal J3 function
(Latner et al., 2000). Therefore recombinant J3x protein
nt monolayers of BSC40 cells in 100-mm dishes were infected at m.o.i.
3x23) or 37°C (J3-7). Total cellular RNA was purified from infected cells
, transferred to nylon membranes and hybridized with radiolabeled
or late (gene F17) gene, as indicated to the left of the autoradiograms.
grams.onflue
t, J3x, J
iograms
e G8),was purified and compared with wild-type protein in
360 XIANG ET AL.
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361VACCINIA GENE J3 MUTANT CHARACTERIZATIONassays for both methyltransferase and poly(A) stimula-
tion.
Construction and purification of His-tagged mutant J3
protein. Wild-type E1 and J3 open reading frames and the
mutant J3x open reading frame were cloned with N-
terminal thioredoxin and polyhistidine tags, overex-
pressed in bacteria, and purified as described under
Materials and Methods. The purity of the proteins was
assessed by SDS–PAGE and Coomassie blue staining
(Fig. 4). The thioredoxin and polyhistidine tags increase
the mass of each protein by ;13 kDa; thus the recom-
binant wt and mutant J3 proteins migrate with an appar-
ent MW of 52 kDa, and the recombinant E1L protein
migrates with an apparent MW of 68 kDa. The identity of
the proteins was confirmed by Western blot analysis
using E1L and J3 antisera (data not shown). The wt and
mutant J3 proteins were purified to near homogeneity.
The E1L protein was significantly contaminated with bac-
terial proteins, but this contamination does not affect the
biochemical activity of the protein or the interpretation of
the results. The E1 protein was not further purified due to
the low yield.
FIG. 3. Structural analysis of the gene F17 late RNA from wt and mu
were infected at m.o.i. 5 10 with wt, J3x, J3-7, or G2A, or m.o.i. 5 5 with
above the autoradiograms. Total cellular RNA was purified from infe
radiolabeled antisense DNA oligonucleotides a–f, as indicated above
length 50 nt) relative to the F17 promoter is shown. [In the F17 gene, t
initiation ATG.] The migration of size markers, in kb, is indicated to th
interpretation of the results shown in (A), with wt and J3 mutant (J3-) t
a broken arrow indicates heterogeneity at the 39 end); a schematic of
coding sequence indicated as the leftmost open box, and the remaind
oligonucleotide probes a–f. (C) Quantification of the data in (A). For ea
FIG. 4. Analysis of purified recombinant J3 and E1 proteins. Recom-
binant wt J3 protein, mutant J3x protein, and wt E1 protein were
subjected to SDS–PAGE followed by Coomassie blue staining. Protein
identities are shown at the top of the gel, migration of molecular weight
markers, in kDa, is shown at the left, and the migration of recombinant
J3 and E1 proteins, confirmed by western analysis, is shown at the
right.lane was then plotted as a percentage of the wt signal for a given probe.Methyltransferase assay. Ribose methyltransferase
activity of wt and J3x J3 proteins was assayed by mea-
suring the transfer of methyl groups from 3H-methyl-
labeled S-adenosylmethionine to the 59cap-0 structure of
brome mosaic virus (BMV) RNA as described under
Materials and Methods (Fig. 5). Three concentrations of
wt J3 protein (16, 8, and 4 mg/ml) were assayed in a time
ourse. The amount of methyl group incorporation in-
reases linearly with time at the lower concentrations of
t J3 protein. From these data we calculate the specific
ctivity of the wt J3 protein to be 560 pmol of methyl
roup/mg protein/min. This compares favorably with the
pecific activity of native wt J3 protein purified from
irions by DEAE–cellulose and CM–Sephadex chroma-
ography, ;930 pmol/mg/min (Moss et al., 1976). No
ethyltransferase activity was detected in the presence
f 16 mg/ml J3x protein, equivalent to the highest con-
centration of wt enzyme tested. We conclude from these
experiments that the J3 G96D mutation in J3x abolishes
the methyltransferase activity of the enzyme.
Poly(A) stimulatory activity assay. Poly(A) polymerase
stimulatory activity was assayed by measuring the addi-
tion of adenylates from ATP to the 39 end of a 59 end-
labeled RNA oligonucleotide substrate, analyzed by gel
electrophoresis and autoradiography as described un-
ected cells. (A) Confluent monolayers of BSC40 cells in 100-mm dishes
incubated at 40°C (wt, J3x, J3x23, and G2A) or 37°C (J3-7) as indicated
lls at 12 h p.i., transferred to nylon membranes, and hybridized with
oradiograms. The position of the middle each oligonucleotide (average
transcribed nucleotide (11) is coincident with the A in the translation
f the autoradiograms. (B): A cartoon showing (from top to bottom) an
pts indicated as arrows (representation of the J3 mutant transcripts as
transcription unit with the promoter indicated as an arrow, the 300-nt
e sequence indicated as the rightmost open box; the map positions of
e, the total radioactivity in each lane was measured, and each mutant
FIG. 5. Methyltransferase activity of wt and mutant J3 proteins.
Wild-type and J3x mutant recombinant J3 proteins were assayed for
transfer of [3H]methyl groups from 3H-methyl-labeled S-adenosylme-
hionine to the 59cap-0 structure of brome mosaic virus (BMV) RNA as
escribed under Materials and Methods. Amounts of protein included
n reactions were varied as indicated. A control reaction, labeled
substrate,” contained no enzyme.tant-inf
J3x23,
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362 XIANG ET AL.der Materials and Methods (Fig. 6). In the absence of
either E1 or J3 proteins, the labeled RNA substrate oli-
gonucleotide migrates faster than a 40-nt DNA marker,
consistent with its length of 34 nt (Fig 6, lane 1). Previous
studies have shown that E1 protein, which carries the
poly(A) polymerase active site, catalyzes the addition of
30–35 adenylates to an RNA primer in a rapid highly
processive burst, followed by a much slower nonproces-
sive addition of adenylates to poly(A) tails that are longer
than 30 nucleotides (Gershon and Moss, 1993a). Consis-
tent with these previous studies, reaction of the RNA
oligonucleotide with E1 protein alone generates a prod-
uct that migrates at ;55 nt, corresponding to addition of
0 A residues to the 39 end of the substrate. When both
1 and wt J3 proteins were included in the reaction,
onger oligoadenylated products were observed (Fig. 6,
anes 3–8), consistent with the previously described
oly(A) stimulatory activity of the J3 protein. The lengths
f polyadenylated products increased with increasing
3/E1 molar ratios. The formation of the polyadenylated
roducts with mutant J3x protein was similar to that
observed with the wt protein (Fig. 6, lanes 9–14). In
several other experiments not shown, the poly(A) stimu-
latory activity of the J3x protein was indistinguishable
from that of the wt protein. We conclude that the J3x
mutation does not affect the polyadenylation stimulatory
FIG. 6. Analysis of poly(A) stimulatory activity of wt and mutant J3
proteins. Wild-type and J3x mutant recombinant J3 proteins were as-
ayed for transfer of adenylates to the 39 end of a 59 32P-labeled RNA
oligonucleotide in the presence of wt E1 protein. Reactions were
incubated for 5 min, a time determined in preliminary experiments to be
in the linear range of a time course. Reaction products were analyzed
by gel electrophoresis and autoradiography. Migration of size markers
(lane M) is shown at the left of the autoradiogram, in nt. The reaction in
lane 1 contains no E1 or J3 proteins. The reaction in lane 2 contains
16.7 nM E1 protein but no J3 protein. Reactions in lanes 3 through 14
contain wt or J3x protein in increasing amounts as indicated at the top
of the autoradiogram. Lanes 3 and 9, 0.07 nM J3 protein; lanes 4 and 10,
0.21 nM J3 protein; lanes 5 and 11, 0.62 nM J3 protein; lanes 6 and 12,
1.86 nM J3 protein; lanes 7 and 13, 5.57 nM J3 protein; lanes 8 and 14,
16.7 nM J3 protein.function of the J3 protein as assayed in vitro. sPolyadenylation in vivo
To determine the effects of the J3x mutation on poly-
adenylation in vivo, the polyadenylation status of RNAs
synthesized during wild-type and mutant viral infections
was analyzed. Published results have shown that in
vaccinia virus-infected cells, cellular RNA is degraded to
50% of its original concentration within 3h p.i. and is
almost totally degraded within 8 h p.i. (Rice and Roberts,
1983). Therefore poly(A)-containing RNAs isolated at
early times (3 h) postinfection should contain both the
cellular and viral RNAs, whereas RNAs isolated at late
times postinfection (8–24 h) should contain predomi-
nantly viral RNAs. To demonstrate that total RNA isolated
from infected cells at late times represents viral RNA, a
pilot experiment was done with RNA isolated from cells
infected with wt virus or with J3-7 (Fig. 7). Total RNA
extracted from virus-infected cells was labeled at the 39
FIG. 7. Analysis of poly(A) length in wt and J3-7 virus infections.
Confluent monolayers of BSC40 cells in 100-mm dishes were infected
with wt or J3-7 viruses at a m.o.i. of 15 incubated at 37°C for varying
amounts of time (indicated above the autoradiogram, in h), and RNA
purified as described under Materials and Methods. Total RNA was 39
end labeled with [32P]pCp, digested with RNases A and T1, and the
abeled, RNase-resistant poly(A) tails were analyzed by gel electro-
horesis and autoradiography. The migration of size markers, in nt, is
hown at the left. M, mock-infected cells.
R
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363VACCINIA GENE J3 MUTANT CHARACTERIZATIONend with [32P]pCp (cytidine 39,59-bisphosphate), digested
with RNase A and RNase T1, and RNase-resistant poly(A)
tails were analyzed by polyacrylamide gel electrophore-
sis and autoradiography. Analysis of RNA isolated from
mock-infected cells revealed that cellular RNAs contain
poly(A) tails averaging ;100 nt in length (Fig. 7, lane 1).
RNA isolated at an early time (3 h) following the wt
infection has a poly(A) tail length identical to that follow-
ing the mock infection. RNA isolated at an early time (3 h)
following the J3-7 infection has a poly(A) tail length that is
slightly decreased in length compared to that in the wt
infection (Fig. 7, lane 7), perhaps representing virus-
induced shortening of poly(A) tails on cellular mRNAs.
RNA isolated from a wt infection at late times has a
poly(A) tail length that is the same or slightly longer than
mock RNA or early wt RNA, averaging ;100 nt (Fig. 7,
lanes 3–6). By contrast, RNA from J3-7-infected cells at
late times displays short poly(A) tails averaging 20–30 nt
in length (Fig. 7, lanes 8–11). This pilot experiment shows
that the J3-7 virus is incapable of making long poly(A)
tails and, more importantly for our analysis, that total
mRNA isolated at late times from infected cells is com-
posed exclusively of RNA (probably predominantly viral)
whose polyadenylation status is controlled by the viral J3
gene product.
Using the wt and J3-7 virus as controls, we analyzed
the poly(A) tail length of three different mutant viruses:
J3x, r51x4 (the parent of J3x, which contains both the
G96D mutation and an additional missense mutation in
the overlap between the C terminus of J3 and the N
terminus of J4), and G2A. Total RNAs isolated from wt or
mutant infected cells at 18 h p.i. were 39 end labeled and
RNase digested, and the lengths of the resistant poly(A)
tails were determined as described above (Fig. 8).
Poly(A) tails from J3-7-infected cells were short, averag-
ing 20–40 nt in length, showing that under these condi-
tions of infection only viral mRNA is measured. The
poly(A) tail length of RNA isolated from cells infected with
J3x, r51x4, and G2A was identical to that of mock RNA
(Fig. 8, lane 1) or to cells infected with wt virus (Fig. 8,
lanes 4–6). We conclude that the poly(A) stimulatory
activities of the J3 protein are intact in the J3 mutants J3x
and r51x4 and that G2 null mutant virus is also compe-
tent for synthesis of wt length poly(A) tails.
DISCUSSION
The experiments reported here strongly suggest that
the vaccinia virus J3 gene product, previously identified
as a (nucleoside-29-O-)-methyltransferase and as a pro-
cessivity subunit for the heterodimeric viral poly(A) poly-
merase (Gershon, 1998), is also an essential positive
regulator of intermediate and late (postreplicative) viral
transcription elongation. Thus infection of cells either
with a J3 null mutant or with a point mutant that abro-
gates the J3 (nucleoside-29-O-)-methyltransferase activity
results in synthesis of 39-truncated late RNA, consistentwith the absence of a positive transcription elongation
factor in the mutant infections. Generalized 39 truncation
of postreplicative transcripts would account for the ob-
served synthesis of abnormally short intermediate and
late RNAs, and translation of abnormally short mRNAs
would account for the observed specific decrease in
synthesis of large but not small intermediate and late
proteins. The phenotype is also consistent with prior
genetic data: growth of the J3 mutants can be rescued by
procedures that enhance transcription elongation, spe-
cifically either treatment with the anti-poxviral drug IBT or
recombination with mutants in gene A18 (Latner et al.,
2000). Importantly, the in vivo experiments described
FIG. 8. Analysis of poly(A) length in wt and mutant virus infections.
Confluent monolayers of BSC40 cells in 100-mm dishes were infected
with wt or mutant viruses (as indicated above the autoradiogram) at a
m.o.i. of 15 and incubated at 37°C for 18 h, and RNA was purified as
described under Materials and Methods. Total RNA was 39 end labeled
with [32P]pCp and digested with RNases A and T1, and the labeled,
Nase-resistant poly(A) tails were analyzed by gel electrophoresis and
utoradiography. The migration of size markers, in nt, is shown at the
eft. M, mock-infected cells.here do not distinguish whether the effects of the J3
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364 XIANG ET AL.mutations are direct or indirect. Thus although we favor
the hypothesis that J3 itself is a positive transcription
elongation factor, we cannot at this point exclude the
possibilities that, for example, RNA cap-1 structures
themselves affect elongation or that there exists a dis-
tinct elongation factor whose synthesis is sensitive to
cap methylation. Resolution of these uncertainties must
await characterization of the J3 protein and other unchar-
acterized elongation factors in an in vitro elongation
system (Lackner and Condit, 2000).
All of our transcription analyses measure steady-state
RNA in vivo, and therefore we cannot formally distinguish
whether the differences in RNA structure we observe
comparing wt and J3 mutant RNAs are attributable to
abnormal RNA synthesis or to abnormal RNA turnover. In
both yeast and mammalian cells, RNA turnover mecha-
nisms exist which degrade RNA exonucleolytically from
either the 59 or 39 end (Gallie, 1998; van Hoof and Parker,
1999). Interestingly, the 59 to 39 pathway is influenced by
oth the RNA cap structure and the poly(A) binding
rotein and thus bears provocative similarities to the
ystem described here that involves a viral function that
nteracts with both RNA 59 ends and 39 ends. However,
he 39 truncation of RNA we have observed is both
pecific and limited, leaving wt quantities of promoter
roximal RNA in J3-mutant-infected cells. The persis-
ence of normal quantities of relatively stable 39-trun-
ated RNA seems inconsistent with any of the degrada-
ion pathways heretofore described, and we therefore
avor the interpretation that the J3 protein affects synthe-
is rather than turnover of RNA. Ultimately proof of this
nterpretation will require a rigorous biochemical char-
cterization of the effects of the J3 protein on transcrip-
ion elongation in vitro.
Our results also provide the first insight into the func-
ion of the poly(A) stimulatory activity of the J3 protein in
ivo. First, both the J3x and J3-7 viruses produce similarly
9-truncated RNAs, despite the fact that J3x retains
oly(A) stimulatory activity, whereas J3-7 lacks poly(A)
stimulatory activity and synthesizes RNAs with short
poly(A) tails. Subtle differences in the size distribution of
J3x and J3-7 RNAs are not attributable to poly(A) stimu-
latory activity, because G2A mutant RNAs, which pos-
sess normal poly(A) tails, are indistinguishable from J3-7
RNAs. Thus the poly(A) stimulatory activity does not
seem to influence transcription elongation. Second, al-
though we have been unable to isolate a stable recom-
binant containing both a J3 null mutation and a gene A18
ts mutation (Latner et al., 2000), IBT treatment neverthe-
less rescues growth of J3-7, without affecting poly(A) tail
length (data not shown). These observations suggest
that at least under some circumstances, long poly(A)
tails are not absolutely required for virus growth. Thus
our results suggest that the poly(A) stimulatory activity of
the J3 protein not only is unrelated to the elongation
factor activity of J3, but in fact may be only semiessential.The observation that a single missense mutationwhich abrogates the J3 (nucleoside-29-O-)-methyltrans-
ferase activity also results in synthesis of 39-truncated
RNAs in vivo raises the intriguing possibility that the
methylase activity is somehow functionally coupled to
transcription elongation. The missense mutation studied,
G96D, affects a glycine that is 20% surface exposed in
the J3 crystal structure and that forms a kink in the alpha
carbon backbone of J3 between two residues, D95 and
R97, both of which form hydrogen bonds with the methyl
donor S-adenosylmethionine (SAM) (Hodel et al., 1996).
Thus replacement of G96 with aspartic acid could easily
compromise binding of SAM to the enzyme, accounting
for the lack of methyltransferase activity. However, the
same mutation could also affect the surface charge of
the protein, thus independently affecting interactions
with other proteins hypothetically involved in regulation
of transcription elongation or termination. If the methyl-
ation and elongation functions of the J3 protein are sep-
arate and independent activities, it should be possible to
construct mutants that are defective in either methylation
or elongation but not both. An abundance of in vitro
mutants of the J3 protein exist (Schnierle et al., 1994; Shi
et al., 1996, 1997), and construction and assay of viruses
containing these mutations should address the relation-
ship between methylation and elongation.
Aside from a stimulation of translation associated with
ribose methylation in maturing oocytes (Kuge et al.,
1998), the in vivo function of the cap-1 structure has yet
to be determined. Apart from the possible link between
methylation and elongation described above, our exper-
iments do not formally address the function of ribose
methylation in vivo, specifically because we have not
attempted to measure ribose methylation of RNA caps in
vivo. Although we expect that the J3 methyltransferase
activity will be missing in our mutant infections, it is
possible that host enzymes may substitute for viral en-
zymes so that cap-1 structures are formed in the ab-
sence of J3 methyltransferase activity. Our experiments
do show, however, that J3 mutant viruses defective in
ribose methyltransferase can be constructed, opening
the door for investigation of the role of cap-1 structures
in vivo.
Infections with J3 mutant viruses resulted in early gene
expression that is indistinguishable from that in a wt
virus infection, demonstrating that the influence of the J3
gene on transcription elongation is highly specific for
intermediate and late genes. This observation empha-
sizes further the fact that early poxvirus transcription
elongation and termination are mechanistically distinct
from intermediate and late transcription elongation and
termination, which in turn seem to be mechanistically
similar. The vaccinia RNA polymerase exists in two
forms, one that transcribes early but not late genes and
one that transcribes late genes but not early genes. The
late-gene-specific RNA polymerase contains eight core
virus-coded subunits only (Wright and Coroneos, 1995).
The enzyme that transcribes early genes contains an
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365VACCINIA GENE J3 MUTANT CHARACTERIZATIONadditional subunit, the H4 gene product, which is re-
quired for initiation at early promoters and which re-
mains tightly associated with the RNA polymerase dur-
ing elongation (Ahn et al., 1994; Deng and Shuman,
1994). Thus the subunit composition of early and late
elongating RNA polymerases reflects a memory of the
class of gene that is being transcribed. Early genes
terminate transcription efficiently at discrete sites in re-
sponse to a specific cis-acting signal in an energy-
dependent process that involves the viral heterodimeric
capping enzyme (genes D1 and D12) and a viral DNA-
dependent ATPase (gene D11) (Shuman et al., 1987;
Christen et al., 1998; Deng and Shuman, 1998). The
postreplicative elongation machinery ignores early ter-
mination signals and terminates inefficiently at numer-
ous sites of unknown sequence composition (Cooper et
al., 1981; Mahr and Roberts, 1984). Genetic and biochem-
ical analyses suggest that elongation and termination of
postreplicative genes are influenced by as many as five
different factors, four of which are virus coded, one of
which is host coded, and all of which are distinct from
factors regulating early gene transcription elongation
and termination. Postreplicative elongation is negatively
regulated in vivo by the A18 gene product, which con-
tains DNA-dependent ATPase (Bayliss and Condit, 1995),
DNA helicase (Simpson and Condit, 1995), and transcript
release activities (Lackner and Condit, 2000), and thus
behaves like a transcription termination factor. A18-cat-
alyzed transcript release in vitro requires an additional
factor found in uninfected cells (Lackner and Condit,
2000), thus implicating a host factor in postreplicative
vaccinia transcription termination. Positive transcription
elongation factors now include both the J3 and G2 (Black
and Condit, 1996) gene products, the latter of which has
no other known function. Whether J3 and G2 contribute
essential activities to the same process or are function-
ally redundant remains to be determined. The G2 protein
associates specifically with the H5 gene product (Black
et al., 1998), an abundant phosphoprotein implicated in
both late transcription and morphogenesis (Kovacs and
Moss, 1996; Beaud and Beaud, 1997; Demasi and Trakt-
man, 2000). Although the J3 protein does not specifically
associate with viral RNA polymerase isolated from viri-
ons (Broyles and Moss, 1987), evidence suggests that
A18, G2, and H5 may associate with a larger complex in
vivo during infection (Black et al., 1998), raising the pos-
ibility that many or all of the postreplicative viral tran-
cription elongation/termination factors may exist in a
arge elongation complex. A wide variety of vertebrate
oxviruses, including variola (Massung et al., 1994),
lastrim (Shchelkunov et al., 2000), molluscum contagio-
ium (Senkevich et al., 1997), Shope fibroma (Willer et al.,
999), and myxoma (Cameron et al., 1999), contain all
hree essential postreplicative elongation factors, A18,
3, and G2, implying that the genes coevolved from a
rimordial vertebrate poxvirus as an integrated elonga-ion regulatory complex. Interestingly, the insect poxvi- (uses Melanoplus sanguinipes Entomopoxvirus (Afonso
t al., 1999), and Amsacta moorei Entomopoxvirus (A.
awden, K. Maggard, and R.W. Moyer, in preparation)
ach contain both A18 and J3 but lack G2, suggesting
hat late gene transcription may have evolved slightly
ifferently in the insect poxviruses.
Despite the specificity of the J3 elongation activity for
ostreplicative genes, the multifunctional J3 protein is
resent throughout infection (Nevins and Joklik, 1977;
nd E. Niles, unpublished observations), packaged in
irions (Moss et al., 1975), and thus provides cap ribose
ethylase and poly(A) stimulatory activities during the
arly as well as postreplicative stages of vaccinia infec-
ion. Interestingly, the A18 (Simpson and Condit, 1994)
nd H5 (P. Traktman, personal communications) proteins
re also present in virions, though their implied role in
arly gene expression remains to be determined. It is
onceivable therefore that the early and postreplicative
ranscription elongation complexes, while displaying dif-
erences in composition and activity, also overlap in
tructure and function. By contrast, the G2 gene product
s synthesized early during infection, is present late dur-
ng infection, but is not packaged in virions and thus
eems to be an exclusively postreplicative gene specific
actor (Meis and Condit, 1991; Black et al., 1998). Further
omparisons of the structure and activity of the early and
ostreplication transcription elongation complexes
hould reveal interesting similarities required for proper
longation of all viral genes, and differences that account
or the apparently different termination mechanisms.
MATERIALS AND METHODS
ells and viruses
The continuous African green monkey kidney cell line
SC40 and conditions for cell culture have been previ-
usly described (Condit and Motyczka, 1981; Condit et
l., 1983). Wild-type vaccinia virus strain WR, the G2 gene
utant G2A, the J3 mutants J3x, J3-7, and r51x4, the
enes J3 and A18 double-mutant J3x23, and the condi-
ions for their growth, infection, and plaque titration have
een previously described (Condit and Motyczka, 1981;
eis and Condit, 1991; Latner et al., 2000). Briefly, G2A is
henotypically IBT dependent (IBTd) and contains an
ngineered 10-bp deletion in gene G2, resulting in a
rameshift at codon 90 and truncation of the 220-amino-
cid protein at position 93. J3x is phenotypically IBTd and
contains a missense mutation in codon 96 of the J3 gene
(G96D). J3-7 is phenotypically IBTd and contains a single
ucleotide deletion in the J3 gene that causes a frame-
hift at codon 49 and truncation of the 333-amino-acid
rotein at position 58. r51x4 is phenotypically IBTd and
ontains two missense mutations in the J3 gene, one in
odon 96 of gene J3 (G96D), and the other in codon
27 of J3 (R327K) within an overlap with the N terminus J4
pen reading frame, where it affects codon 22 of gene J4D22N). J3x23 is phenotypically wt [ts1 and IBT sensitive
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366 XIANG ET AL.(IBTs)], but forms smaller plaques than wt. J3x23 is a
recombinant between J3x and the gene A18 ts mutant,
Cts23. IBT was prepared fresh before each use and
applied at a final concentration of 45 mM as previously
escribed (Pacha and Condit, 1985).
lasmid constructs
pET32aJ3G96D, pET32aJ3R, and pET32aE1L contain
he precise coding regions of the vaccinia virus J3 gene
3x mutant, the wt J3 gene, and the wt E1 gene respec-
ively, cloned in the expression vector pET32a (Novagen).
he resulting clones express an N-terminal fusion of
hioredoxin- and polyhistidine-tag sequences with the
3x gene product, the wt J3 gene product, or the wt E1
ene product. pET32aJ3G96D was constructed by PCR
mplification of the J3 coding sequence from genomic
51x4 viral DNA, prepared as previously described (Lat-
er et al., 2000), using primers which positioned a syn-
hetic NcoI site at the 59 end and a synthetic EcoRI site
at the 39 end. The 39 primer contained a mismatch such
that PCR amplification reverted the mutation at codon
327 of gene J3 in r51x4 back to wt sequence. The PCR-
amplified J3 DNA was trimmed with NcoI and EcoRI and
cloned into NcoI- and EcoRI-cleaved pET32a. The se-
quence of the insert was confirmed by DNA sequence
analysis. For construction of pET32aJ3R, the entire cod-
ing region of gene J3, originally excised from pPG175
(Gershon and Moss, 1993b) and containing an NcoI site
at the J3 translation initiation codon and a HindIII site
downstream of the J3 translation termination codon, was
cloned into NcoI, HindIII-cleaved pET32a. For construc-
tion of pET32aE1L, entire coding region of gene E1, PCR
amplified from wt viral DNA using primers that placed an
NcoI site at the E1 translation initiation codon and a
HindIII site downstream of the E1 translation termination
codon, was cloned into NcoI, HindIII-cleaved pET32a.
The sequence of the insert was confirmed by DNA se-
quence analysis. All three pET32a-based plasmids were
transformed into bacterial strain AD494(DE3)pLysS ac-
cording to the pET system manual (Novagen).
Riboprobe template clones pGEM-VGF, pGEM-30K,
and pGEM-11K (Baldick et al., 1992), clones used for
synthesis of riboprobes specific for the 59 ends of stan-
dard early (gene C11), intermediate (gene G8), and late
(gene F17) genes, respectively, were kindly provided by
Bernard Moss (National Institutes of Health).
Antibodies
Polyclonal anti-J3 serum was raised in rabbits against
the thioredoxin–J3 protein purified as described below.
Polyclonal anti-E1 serum was raised in rabbits against
the thioredoxin–E1 fusion protein purified by preparative
gel electrophoresis of protein solubilized from inclusion
bodies formed in induced Escherichia coli. Rabbits were
initially injected with 250 mg protein in Freund’s completedjuvant followed by three boosts in Freund’s incomplete
djuvant.
rotein pulse-labeling
Pulse-labeling of proteins in virus infected cells was
one as described previously (Condit and Motyczka,
981). Briefly, confluent 35-mm dishes of BSC40 cells
ere infected with wt or mutant virus at a high m.o.i. in
the absence of IBT and incubated at 37 or 40°C as
indicated in the figure legends. At various times postin-
fection, cells were metabolically labeled with [35S]methi-
onine for 15 min. Cells were lysed on the dishes by
addition of SDS–polyacrylamide gel electrophoresis
(PAGE) sample buffer, and solubilized proteins were an-
alyzed by SDS–PAGE. The gels were Coomassie blue
stained, dried, and autoradiographed.
Isolation of total cellular RNA
Confluent 100-mm dishes of BSC40 cells were in-
fected with wt or mutant virus at a high m.o.i. in the
absence of IBT and incubated at 37 or 40°C as indicated
in figure legends. At various times after infection, total
cellular RNA was purified using RNeasy Total RNA puri-
fication columns as described by the manufacturer
(Qiagen, Inc., Chatsworth, CA). The RNA was eluted
from the column with DEPC-treated H2O and quantified
y measuring absorbence at 260 nm.
orthern analysis
Northern transfers were prepared as follows. Two mi-
rograms of purified RNA in water was adjusted to a final
oncentration of 0.363 MOPS buffer (13 MOPS buffer 5
20 mM MOPS, 8 mM sodium acetate, 1 mM EDTA, pH
7.0), 1.6 M formaldehyde, 36% formamide, in a final vol-
ume of 13.75 ml. The samples were heated to 65°C for
5 min, then chilled on ice. One microliter of 1 mg/ml
thidium bromide and 2 ml of RNA loading buffer (50%
glycerol, 1 mM EDTA, 0.0 5% bromphenol blue, 0.0 5%
xylene cyanol) were added to each sample before load-
ing on the gel. The samples were electrophoresed at 80
V through 1.2% agarose gels containing a final concen-
tration of 13 MOPS buffer and 0.37 M formaldehyde in
an electrophoresis buffer containing 13 MOPS buffer
and 0.23 M formaldehyde. RNA was transferred to
GeneScreen membrane (New England Nuclear) in a
buffer containing 30 mM sodium phosphate, pH 6.5, and
the RNA was UV crosslinked to the membrane. Mem-
branes were hybridized with either uniformly labeled
riboprobes or 59-end-labeled DNA oligonucleotides as
described below.
Riboprobes were synthesized essentially as described
in the Promega Protocols and Applications Guide. Reac-
tions (35 ml) contained 13 optimized transcription buffer
Promega), 11 mM DTT, 40 units RNase inhibitor (Pro-
ega), 0.4 mM ATP, GTP, and UTP, 11 mM unlabeled CTP,
3250 mCi [a P]CTP (3000 Ci/mmol), 1 mg linearized tem-
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367VACCINIA GENE J3 MUTANT CHARACTERIZATIONplate DNA, and 20 units T7 RNA polymerase. Reactions
were incubated at 37°C for 1 h. One unit of RNase-free
DNase (Promega) was added and the reactions were
incubated for 15 min at 37°C. Sixty-five microliters of
STE/SDS (10 mM Tris–HCl, pH 8.0, 1 mM EDTA, 0.1 M
NaCl, 0.1% SDS) was added, and the samples were
extracted with an equal volume of phenol:chloroform.
The aqueous phase was precipitated by addition of 100
ml 4 M ammonium acetate, 120 ml isopropanol, and 1 ml
f 20 mg/ml glycogen and incubation at RT for 30 min.
he precipitate was collected by centrifugation and re-
uspended in 50 ml DEPC-treated water.
Anti-sense DNA oligonucleotide probes (45–56 mers)
used for Northern analysis of F17 gene transcripts were
labeled as follows: lyophilized oligonucleotides (Gene-
med Synthesis Inc., San Francisco, CA) were resus-
pended in water at a final concentration of 200 ng/ml.
Two hundred nanograms of oligonucleotide was added
to 11 ml water and warmed to 70°C for 1 min, then chilled
on ice. Reactions were adjusted to a final volume of 20 ml
y addition of 2 ml of 103 T4 polynucleotide kinase buffer
Promega), 50 mCi [g-32P]ATP (6000 Ci/mmol), and 10
units T4 polynucleotide kinase (Promega). Reactions
were incubated at 37°C for 1 h. One microliter of 0.5 M
EDTA was added to stop the reaction followed by the
addition of 125 ml of TE (10 mM Tris–HCl, pH 7.5, 1 mM
EDTA). Unincorporated label was removed by two cen-
trifugations through Sephadex-G25-spun columns es-
sentially as described and the total TCA precipitable
radioactivity in the final eluate was determined.
For hybridization with riboprobes, membranes were
prehybridized for 2 h at 55°C in 10 ml buffer containing
50 mM Tris–HCl, pH 7.5, 1 M NaCl, 50% formamide, 1%
SDS, 0.1% sodium pyrophosphate, 103 Denhardt’s (0.2%
BSA, 0.2% polyvinylpyrrolidone, 0.2% Ficoll), 10% dextran
sulfate, 0.1 mg/ml salmon sperm DNA. Membranes were
then hybridized overnight at 55°C in the same buffer
containing 107 cpm of riboprobe. Following hybridization,
embranes were washed once at room temperature in
.1% SDS, 0.13 SSC and three times at 65°C in 1.0% SDS,
.13 SSC, and exposed to film.
For hybridization with labeled DNA oligonucleotides,
embranes were prehybridized in 10 ml buffer contain-
ng 63 SSC, 0.1% SDS, 103 Denhardt’s reagent, and 100
mg/ml salmon sperm DNA for 2 h at 42°C, then hybrid-
ized overnight in the same buffer containing 107cpm
abeled oligonucleotide probe. Membranes were
ashed twice for 20 min at 50°C in 53 SSC, 0.1% SDS
nd exposed to film. The amount of label hybridized to
ach sample was quantified after autoradiography using
phosphorimager (Molecular Dynamics).
urification of His-tagged J3 and E1L proteins
The bacterial overexpression and affinity purification
f polyhistidine-tagged E1, J3, and J3x proteins were
one according to the pET system manual (Novagen).riefly, bacteria containing pET32aE1L, pET32aJ3, or
ET32aJ3G96D were grown in 50 ml LB containing 150
mg/ml ampicillin and 34 mg/ml chloramphenicol at 37°C
overnight. Thirty milliliters of the preculture was used to
inoculate a 3-L culture that was grown at 37°C. After the
OD600 of the 3-L culture reached 0.6, the culture was
induced by addition of IPTG (100 mM stock) to a final
concentration of 0.1 mM and further incubated at room
temperature overnight. Bacterial cells were sedimented,
and the pellets were resuspended in 40 ml lysis buffer
[13 binding buffer (5 mM imidazole, 500 mM NaCl, 20
mM Tris–HCl, pH 7.9), 1 mM PMSF, 0.01% NP40, 1 mM
MgCl2, and 2.5 mg DNase I] and placed on ice. Cells
ere broken by sonication, cell debris was removed by
entrifugation, and the supernatant was applied to a
.5-ml precharged Ni21 column. The column was washed
with 10 vol of binding buffer (5 mM imidazole, 500 mM
NaCl, 20 mM Tris–HCl, pH 7.9) and then with 6 vol of
wash buffer (5 mM imidazole, 500 mM NaCl, 20 mM
Tris–HCl, pH 7.9). The proteins were eluted from the
column with 6 vol of elution buffer (100 mM imidazole,
500 mM NaCl, 20 mM Tris–HCl, pH 7.9). Fractions were
analyzed by SDS–gel electrophoresis followed by Coo-
massie blue staining and Western blot analysis using
rabbit polyclonal anti-J3 or anti-E1 serum. Fractions con-
taining J3 or E1 proteins were pooled and dialyzed in
Buffer A (25 mM Tris–HCl, pH 8, 1 mM EDTA, 10 mM
b-mercaptoethanol, 50 mM NaCl, and 10% glycerol). E1
protein was used without further purification, and J3
proteins were purified further by chromatography on
Q–Sepharose. The pooled dialyzed J3 proteins were
loaded on a 2.5 ml Q–Sepharose column and eluted
using a 40-ml gradient containing 50–500 mM NaCl in
Buffer A. Fractions were analyzed by SDS–gel electro-
phoresis followed by Coomassie blue staining and West-
ern blot analysis using rabbit polyclonal anti-J3. Fractions
containing J3 protein were pooled and used without
dialysis. Final protein concentration was determined by
the Bradford assay, using bovine serum albumin (BSA) as
a standard.
Methyltransferase assay
Ribose methyltransferase activity was assayed by
measuring the transfer of methyl groups from 3H-methyl
labeled S-adenosylmethionine to the 59cap-0 structure of
brome mosaic virus (BMV) RNA (Barbosa and Moss,
1978). Purified BMV was kindly provided by Dr. Ernest
Hiebert (University of Florida). For RNA extraction, puri-
fied brome mosaic virus was mixed with 10% SDS to a
final concentration of 2%. The mixture was extracted
twice with an equal volume of phenol-chloroform. The
RNA was ethanol precipitated, dissolved in RNase-free
water, and quantified by measuring the absorbance at
260 nm The purity and integrity of the extracted RNA
were assessed by electrophoresis on a 1.2% formalde-
hyde–agarose gel.
b
D
m
a
f
r
r
s
I
a
o
s
A
(
t
D
i
m
c
(
t
f
t
t
s
o
p
H
n
v
S
R
t
f
b
e
t
L
o
i
B
B
B
B
B
B
C
368 XIANG ET AL.Methyltransferase reactions contained 100 mg/ml
rome mosaic virus RNA, 25 mM HEPES, pH 8.3, 1 mM
TT, and 1 mM Ado[methyl-3H]Met (15 Ci/mmol, Amer-
sham) and the indicated amounts of J3 protein. At various
times during incubation at 37°C, 50-ml samples were
transferred to 50 ml of 4% SDS. The total 100-ml reaction
ixture was then spotted onto DEAE–cellulose filters,
nd the filters were washed with 5% sodium phosphate
our times, once with water and twice with ethanol to
emove the unincorporated Ado[methyl-3H]Met. Incorpo-
ation of methyl groups into RNA was determined by
cintillation counting.
n vitro polyadenylation assay
The RNA oligonucleotide used as a substrate in poly-
denylation assays corresponds to the 39 terminal 34 nt
f a polyadenylated vaccinia virus early gene VGF tran-
cript before polyadenylation and has the sequence 59
UAUUUAUAAAAAUGCUAAGUAUGCGAUGUAUCU 39
Deng and Gershon, 1997). The oligonucleotide was syn-
hesized chemically and purified by HPLC (Cruchem Inc.,
ulles, VA). The RNA oligonucleotide was 59 end labeled
n a 50-ml reaction containing 50 mM Tris–HCl (pH 8.0), 5
M DTT, 10 mM MgCl2, 10 mCi [g
32P]ATP at a final
oncentration of 1 mM, 20 units T4 polynucleotide kinase
New England Biolabs), and 50 pmol RNA oligonucleo-
ide. The reaction was incubated at 37°C for 30 min,
ollowed by an incubation at 65°C for 15 min.
Poly(A) polymerase activity was assayed by measuring
he incorporation of adenylates from ATP to the 39 end of
he 59 end-labeled RNA oligonucleotide (Deng and Ger-
hon, 1997). Reactions (50 ml) contained 5 ml of the
ligonucleotide labeling reaction mix described above (5
mol of 59 32P-labeled RNA oligonucleotide), 50 mM Tris–
Cl (pH 9.0), 4.5 mM DTT, 60 mM NaCl, 1 mM ATP, 16.7
M E1 protein, and varying amounts of J3 protein. At
arious times of incubation at 37°C, 2- ml samples were
transferred to 2 ml of formamide containing 0.1% (vol/vol)
DS and 2.5 mM EDTA. The total 4-ml reaction was
resolved on 12% polyacrylamide/8 M urea gels in TBE.
The gel was fixed in 10% acetic acid, dried, and then
autoradiographed.
mRNA 39 end labeling and poly(A) measurement
Total RNA isolated from BSC40 cells infected with wt
or mutant viruses was 39 end labeled with 32pCp and
NA ligase (Minvielle-Sebastia et al., 1998). The reac-
ions (30 ml) contained 1 mg total RNA, 20 mCi [32P]pCp
(cytidine 39,59-bisphosphate, ICN), 50 mM HEPES, pH
8.3, 10 mM MgCl2, 3.3 mM DTT, 10% DMSO, 10 mg
acetylated BSA, 50 mM ATP, 10 units RNasin, and 20 units
T4 RNA ligase. Reactions were incubated on ice for
12–16 h. Labeled RNA was digested with 4 mg RNase A
and 80 U RNase T1 in a 80-ml reaction containing 10 mM
Tris–HCl, pH 7.4, 300 mM NaCl, and 30 mg tRNA at 37°C
or 2 h. The reaction was stopped by adding 20 ml of stopuffer (130 mM EDTA, 2.5% SDS) and extracted with
qual volume of phenol/chloroform. RNA was precipi-
ated with ethanol and dissolved in RNase-free water.
abeled RNA products were analyzed by electrophoresis
n 8% polyacrylamide urea gels in TBE. Gels were fixed
n 10% acetic acid, dried, and then autoradiographed.
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